Novel treatment shows promise against rare cancer in kids
A novel treatment using supercharged immune cells appears to work against tumors in children with a rare kind of cancer, researchers reported Wednesday.
Apr 6, 2023
0
7
A novel treatment using supercharged immune cells appears to work against tumors in children with a rare kind of cancer, researchers reported Wednesday.
Apr 6, 2023
0
7
Patients suffering from Crohn's disease, a chronic inflammatory intestinal disorder, develop painful constrictions in the bowel. Due to a lack of methods until now, these complications cannot be characterized with sufficient ...
Apr 5, 2023
0
12
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
A National Institutes of Health team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 ...
Mar 29, 2023
0
7
A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Mar 28, 2023
0
2
Brienne Miner, MD, MHS, assistant professor of medicine (geriatrics), loves to talk about sleep. She first became interested in the subject when she noticed the prevalence of sleep problems among her older patients, and the ...
Mar 28, 2023
0
16
Providing an overview of the submissions process and examples of U.S. Food and Drug Administration (FDA) applications for Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD), a new article can help ...
Mar 27, 2023
0
2
Many cancer patients undergo treatment with multiple drugs, each of which attacks cancer in a different way, so the combination fights cancer on many fronts. But more drugs mean higher risks of side effects.
Mar 23, 2023
0
18
A team of researchers at the Keck School of Medicine of USC have found a drug with the potential for curbing painful hyperinflammation from osteoarthritis, according to results of an animal study.
Mar 22, 2023
0
836
Abemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, ...
Mar 10, 2023
0
1